---
title: "\"New Stock Listing\" MICOT PHARMA-B debuted with a rise of 1.03 times near the highest price, earning HKD 3,740 per lot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290663773.md"
description: "MICOT PHARMA-B closed at HKD 36.9 on its first day of listing, up 1.03 times from the offering price of HKD 18.2, close to the highest price of HKD 37.1. The paper profit per lot is HKD 3,740. The stock was oversubscribed approximately 1,180 times in the Hong Kong public offering, with the final offering price set at the lower limit. The company raised approximately HKD 1.057 billion in the IPO, and the international offering was also oversubscribed"
datetime: "2026-06-24T08:08:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290663773.md)
  - [en](https://longbridge.com/en/news/290663773.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290663773.md)
---

# "New Stock Listing" MICOT PHARMA-B debuted with a rise of 1.03 times near the highest price, earning HKD 3,740 per lot

According to the Economic News Agency on the 24th, MICOT PHARMA-B (02335) made its debut today, closing at HKD 36.9, which is 1.03 times higher than the offering price of HKD 18.2; a total of 11.33 million shares were traded, involving HKD 379 million. The stock has a board lot of 200 shares, and not considering transaction fees, each board lot has a paper profit of HKD 3,740.

The stock opened at HKD 34.02, which is 86.9% higher than the offering price, with a highest price of HKD 37.1 and a lowest price of HKD 32.2.

MICOT PHARMA-B announced that the final offer price was HKD 18.2 per share, which is the lower limit of the pricing. Approximately 154,000 people applied for the Hong Kong public offering, with an oversubscription of about 1,180.46 times. Among the 44,000 people who subscribed for a board lot of 200 shares, 1,322 were allocated shares, with an allocation ratio of 3%. To secure 1 board lot, one would need to subscribe for 300,000 shares or 1,500 board lots. The stock closed at HKD 35.6 in the grey market yesterday (23rd), up 95.6% from the offering price, with a paper profit of HKD 3,480 per board lot.

The group indicated that "top hammer flying" involved 2.9028 million shares, with 323 applicants each receiving 600 shares, and 169 of them receiving an additional allocation of 200 shares, resulting in an allocation ratio of 0.02%. The shares offered in the Hong Kong public offering accounted for 10% of the total shares offered, while the international offering was oversubscribed by 1.52 times. The group raised approximately HKD 1.057 billion through the IPO. Given the high concentration of equity among a few shareholders, even small transactions may lead to significant price fluctuations. (vs)

### Related Stocks

- [02335.HK](https://longbridge.com/en/quote/02335.HK.md)

## Related News & Research

- [Everest Medicines enters China commercialization collaboration with Hainan Herui for budesonide enteric capsules](https://longbridge.com/en/news/290642767.md)
- [HJ Science stumbles in Hong Kong debut after gray market surge](https://longbridge.com/en/news/290804812.md)
- [TYK Medicines shareholders pass Articles of Association amendments at AGM](https://longbridge.com/en/news/290549909.md)
- [Antengene Launches HK$50 Million Share Buyback Plan](https://longbridge.com/en/news/290748857.md)
- [Asymchem Aligns H Share Register Closure for Dividend and Shareholder Meetings](https://longbridge.com/en/news/290807877.md)